Recombinant, octavalent group A streptococcal M protein vaccine

This publication has 22 references indexed in Scilit:

• Group A Streptococcus-Liposome Elisa Antibody Titers To Group A Polysaccharide And Opsonophagocytic Capabilities Of The Antibodies
  The Journal of Infectious Diseases, 1995
• Acute rheumatic fever in Auckland, New Zealand
  The Pediatric Infectious Disease Journal, 1994
• Epidemiologic Analysis of Group A Streptococcal Serotypes Associated with Severe Systemic Infections, Rheumatic Fever, or Uncomplicated Pharyngitis
  The Journal of Infectious Diseases, 1992
• Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A
  New England Journal of Medicine, 1989
• Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.
  The Journal of Experimental Medicine, 1987
• Resurgence of Acute Rheumatic Fever in the Intermountain Area of the United States
  New England Journal of Medicine, 1987
• Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.
  The Journal of Experimental Medicine, 1986
• Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.
  The Journal of Experimental Medicine, 1985
• Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.
  The Journal of Experimental Medicine, 1983
• Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci.
  The Journal of Experimental Medicine, 1980